Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?

[1] Bristow RE(2000)A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 1532-1540

[2] Duska LR(2004)Cancer of the ovary N Engl J Med 351 2519-2529

[3] Lambrou NC(1999)Surgery during chemotherapy and at relapse of ovarian cancer Ann Oncol 10 3-7

[4] Fishman EK(1996)Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1-6

[5] O’Neill MJ(2004)PET-CT in recurrent ovarian cancer: initial observations Radiographics 24 209-223

[6] Trimble EL(1985)Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer Am J Obstet Gynecol 151 981-986

[7] Cannistra SA(1996)Use of CA 125 in follow-up of ovarian cancer Lancet 348 191-192

[8] Berek JS(1995)Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan Eur J Gynaecol Oncol 16 123-129

[9] Tropé C(1998)Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history Clin Imaging 22 364-370

[10] Vergote I(2000)Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer Eur J Gynaecol Oncol 21 599-602

[1] Bristow RE(2000)A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 1532-1540

[2] Duska LR(2004)Cancer of the ovary N Engl J Med 351 2519-2529

[3] Lambrou NC(1999)Surgery during chemotherapy and at relapse of ovarian cancer Ann Oncol 10 3-7

[4] Fishman EK(1996)Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1-6

[5] O’Neill MJ(2004)PET-CT in recurrent ovarian cancer: initial observations Radiographics 24 209-223

[6] Trimble EL(1985)Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer Am J Obstet Gynecol 151 981-986

[7] Cannistra SA(1996)Use of CA 125 in follow-up of ovarian cancer Lancet 348 191-192

[8] Berek JS(1995)Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan Eur J Gynaecol Oncol 16 123-129

[9] Tropé C(1998)Thin-section CT follow-up of metastatic ovarian carcinoma correlation with levels of CA-125 marker and clinical history Clin Imaging 22 364-370

[10] Vergote I(2000)Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer Eur J Gynaecol Oncol 21 599-602